Figure 3.
Calculated nevirapine (NVP) minimal concentrations (continuous line) and 90% confidence intervals (dashed lines) vs. bodyweight in children, following the European Medicines Agency (EMA) dosing recommendations (A) and the World Health Organization (WHO) dosing recommendations (B). The horizontal continuous lines represent the minimal concentration targets for efficacy (3 mg l−1) and toxicity (8 mg l−1), respectively